Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

When Steroids Cause Psychosis

Jane P. Gagliardi, MD, MHS, Andrew J. Muzyk, PharmD, & Shannon Holt, PharmD  |  Issue: October 2010  |  October 1, 2010

Figure 1: Spectrum of psychiatric symptoms associated with corticosteroid use

click for large version

Background

Corticosteroids are used to treat inflammatory manifestations of many rheumatologic conditions. Doses necessary to control disease are frequently high (e.g., 1 mg/kg or greater), and therapy may be maintained for prolonged periods of weeks to months. In this setting, one out of every two to three patients prescribed steroids may develop psychiatric symptoms including psychosis, mania, delirium, and depression. The most common symptoms reported with corticosteroid therapy are hypomania, mania, and psychosis.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Psychiatric Symptoms Associated with Corticosteroids

Psychiatric symptoms have been documented in association with the use of corticosteroids since these agents were first introduced in the 1950s.2 Corticosteroid-induced psychosis refers to a spectrum of psychiatric symptoms ranging from subtle mood changes to memory deficits to frank psychosis that can occur at any time during treatment (See Figure 1, p. 40).3 Mania and hypomania are reported most commonly (35%), followed by depressive symptoms (28%) and psychotic reactions (24%).2 Psychiatric symptoms typically develop three to four days after the initiation of corticosteroid therapy, although symptoms can occur at any time, including after cessation of therapy.

Symptoms may last a few days or persist for three weeks or more.2 A prospective study of outpatients with pulmonary disease who received 40 mg or more of corticosteroids for at least a week demonstrated a significant increase in measurable manic symptoms. The study also identified a subset of patients who developed dysphoric symptoms. These patients met criteria for post-traumatic stress disorder and were more likely to discontinue corticosteroids due to difficulties tolerating the mood symptoms.4

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The pathophysiology of corticosteroid-induced psychosis remains poorly understood, although it is generally accepted that abnormalities of the hypothalamo–pituitary–adrenal (HPA) axis can result in mood disorders. For example, syndromes involving excess or inadequate cortisol production can have psychiatric manifestations. Cushing’s syndrome is associated with anxiety, euphoria, depression, and psychosis, whereas Addison’s disease can produce fatigue, low energy, decreased appetite, and symptoms consistent with neurovegetative symptoms of depression.

In the 1970s and 1980s, the psychiatric community showed interest in the use of the dexamethasone suppression test for the diagnosis of endogenous versus characterologic depression. Although the test has not been incorporated into standard care, it nevertheless points to an important relationship between the regulation of glucocorticoid production and mood disturbance.5 Whether corticosteroid-associated psychiatric symptoms are related to hippocampal effects, suppression of the HPA by dopamine neurotransmission, or other direct or indirect effects of corticosteroids is not well understood.6-8

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:LupusPsychosisSLESteroidSystemic lupus erythematosusSystemic sclerosis

Related Articles
    Course of treatment over time

    Case Report: The Hairdresser Who Couldn’t Comb Her Hair

    November 19, 2018

    Polymyalgia rheumatica (PMR) is an inflammatory rheumatic condition characterized by pain and morning stiffness at the neck, shoulders and hip girdle. It can be associated with giant cell arteritis (GCA); in fact, the two disorders may represent a continuum of the same disease process. This case describes a patient who initially refused treatment for PMR…

    Can Systemic Inflammation Influence Mood?

    August 17, 2015

    The Friday night press release: When a politician or any public figure needs to disclose unfavorable news, chances are they will release it sometime on a late Friday afternoon or evening, hoping that nobody is paying attention. In fact, this behavior was coined “the take out the trash day” on the television political drama, The…

    Depression in Rheumatoid Arthritis

    November 1, 2012

    Examining the psychological and health-related comorbidities of rheumatoid arthritis patients with depression

    Chronic Pain: The Psychiatric Perspective

    January 1, 2015

    Why rheumatic pain is more than a joint issue

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences